Shopping Cart
- Remove All
- Your shopping cart is currently empty
AM-5308 is a kinesin KIF18A inhibitor that can be used to study cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $148 | In Stock | |
5 mg | $372 | In Stock | |
10 mg | $562 | In Stock | |
25 mg | $1,120 | In Stock | |
50 mg | $1,780 | In Stock | |
100 mg | $2,880 | In Stock |
Description | AM-5308 is a kinesin KIF18A inhibitor that can be used to study cancer. |
In vitro | AM-5308 and AM-1882 have a favorable in vitro profile against a panel of normal cell types, which is distinct from myelosuppressive and neurotoxic anti-mitotic agents. Nevertheless, higher micromolar concentrations of AM-5308 and AM-1882 may adversely affect normal cells. [1] |
In vivo | Mice with established tumors were administered vehicle, AM-1882 at 50 or 100 mg per kg or AM-5308 at 25 or 50 mg/kg daily for 18 d. AM-1882 and AM-5308 inhibited tumor growth with evidence of tumor regression. [1] |
Alias | AM5308 |
Molecular Weight | 529.65 |
Formula | C26H35N5O5S |
Cas No. | 2410796-89-1 |
Smiles | C(NC=1N=C(C=CC1)N2C[C@@H](C)OCC2)(=O)C3=C(N4CCC5(CC5)CC4)C=C(NS(CCO)(=O)=O)C=C3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (151.04 mM.), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.